RENASANT CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.31 USD | +1.28% |
|
+7.27% | +1.57% |
| Oct. 23 | Renasant Corporation, Q3 2024 Earnings Call, Oct 23, 2024 | |
| Oct. 22 | Renasant Q3 Adjusted Earnings Fall, Revenue Rises; Shareholders Approve First Bancshares Deal | MT |
Highlights: Renasant Corporation
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The company appears to be poorly valued given its net asset value.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses: Renasant Corporation
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Ratings Chart: Renasant Corporation
Source: Surperformance
ESG chart: Renasant Corporation
Source: MSCI
| Composite Fundamentals | Composite Valuation | Composite Momentum | Capi. ($) | ||
|---|---|---|---|---|---|
| 2.28B | |||||
| 711B | |||||
| 358B | |||||
| 301B | |||||
| 250B | |||||
| 200B | |||||
| 199B | |||||
| 176B | |||||
| 170B | |||||
| 162B | |||||
| Average | 253B | ||||
| Weighted average by Cap. |
Investor Rating
Trading Rating
ESG MSCI
BBB
Financials
Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
ESG
Environment
Social
Governance
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- RNST Stock
- Ratings Renasant Corporation